MLchartDataset catalogue

soblidotin

Term · Oncology and biomedicine · MLC-T-ONC-007841

  1. A substance being studied in the treatment of cancer. It is a type of tubulin inhibitor. Also called TZT-1027.

  2. A dolastatin-10 derivative. Soblidotin inhibits tubulin polymerization, resulting in cell cycle arrest and induction of apoptosis.

Table 1. Record
IdentifierMLC-T-ONC-007841
FieldOncology and biomedicine
SynonymsTZT-1027
ReferencesNCI Dictionary of Cancer Terms; National Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON 
{
  "id": "MLC-T-ONC-007841",
  "term": "soblidotin",
  "field": "Oncology and biomedicine",
  "definitions": [
    "A substance being studied in the treatment of cancer. It is a type of tubulin inhibitor. Also called TZT-1027.",
    "A dolastatin-10 derivative. Soblidotin inhibits tubulin polymerization, resulting in cell cycle arrest and induction of apoptosis."
  ],
  "synonyms": [
    "TZT-1027"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms",
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/soblidotin/"
}

Record 15,119 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.